About
Viehbacher graduated from Queen's University in Kingston, Ontario, Canada, with a Bachelor of Commerce degree. He began his career at PricewaterhouseCoopers and later worked at GlaxoSmithKline before becoming chief executive of Sanofi. Biogen's proxy statement also lists him as a trustee of Northeastern University and a member of the Board of Fellows of Stanford Medical School. Other drug and biotechnology leaders with pages on Whoo include Vertex's Reshma Kewalramani and Gilead's Daniel O’Day.
Whoo compiled this page from public sources: SEC, Biogen 2026 proxy statement, Biogen leadership page, Wikipedia, SEC, Biogen October 2026 results release. It is not affiliated with or endorsed by Chris Viehbacher. Are you Chris Viehbacher? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
President and Chief Executive Officer — Biogen
2022 – Present
- Chief executive and board member since November 2022
- Boston-based investment fund focused on healthcare
- Various roles at GlaxoSmithKline
- Began his career at PricewaterhouseCoopers
Managing Partner — Gurnet Point Capital
2015 – 2022
Global Chief Executive Officer — Sanofi
2008 – 2014